Lefebvre Samenvattingen, Aantekeningen en Examens

Which of the following is a dose-limiting toxicity of irinotecan? Diarrhea Miosis Vomiting Alopecia Diarrhea Answer: Diarrhea is the dose-limiting toxicity for irinotecan. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 44(t). Administration of filgrastim maintains the dose intensity of a treatment regimen by reducing the: occur...

ONCC PRACTICE TESTS (OCN - CARE CONTINUUM) WITH COMPLETE SOLUTIONS 100% Which of the following is an advantage of an implanted vascular access device over a tunneled central venous catheter? Decreased risk of infection Short-term use Low cost of insertion Unlimited ability to access - correct answer Decreased risk of infection Answer: Implanted ports have a lower risk of infection than tunneled central venous catheters. Reference: Camp-Sorrell, D., & Matey, L. (Eds.). (2017)....

A patient demonstrates an adequate understanding of the teaching provided regarding chemotherapy and myelosuppression by stating: "Myelosuppression is: a potential side effect of many cancer treatments." unintentional prior to a bone marrow transplant." when laboratory values show an elevation in the white blood cell count." the overreaction of the body's immune system to a medication." Correct Answer: a potential side effect of many cancer treatments." Answer: Chemotherapy will d...

Which of the following is a dose-limiting toxicity of irinotecan? Diarrhea Miosis Vomiting Alopecia - correct answer Diarrhea Answer: Diarrhea is the dose-limiting toxicity for irinotecan. Reference: Polovich, M., Olsen, M., & LeFebvre, K. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society, p. 44(t). Administration of filgrastim maintains the dose intensity of a treatment regimen by re...

A patient with cancer is considering entering a clinical trial that compares the current standard treatment with an investigational chemotherapeutic agent. This is an example of which phase of a clinical trial? 3 4 1 2 Correct Answer: 3 Answer: Phase 3 clinical trials have a primary goal of establishing efficacy and comparing with the current standard. Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society, p. 285(t). 2 What is th...

A patient with cancer is considering entering a clinical trial that compares the current standard treatment with an investigational chemotherapeutic agent. This is an example of which phase of a clinical trial? 3 4 1 2 - correct answer 3 Answer: Phase 3 clinical trials have a primary goal of establishing efficacy and comparing with the current standard. Reference: Eggert, J. (Ed.). (2017). Cancer basics (2nd ed.). Pittsburgh, PA: Oncology Nursing Society, p. 285(t). What i...

Which of the following is an advantage of an implanted vascular access device over a tunneled central venous catheter? Decreased risk of infection Short-term use Low cost of insertion Unlimited ability to access Decreased risk of infection Answer: Implanted ports have a lower risk of infection than tunneled central venous catheters. Reference: Camp-Sorrell, D., & Matey, L. (Eds.). (2017). Access device standards of practice for oncology nursing. Pittsburgh, PA: Oncology Nursing Soc...

Which of the following is an advantage of an implanted vascular access device over a tunneled central venous catheter? Decreased risk of infection Short-term use Low cost of insertion Unlimited ability to access Correct Answer: Decreased risk of infection Answer: Implanted ports have a lower risk of infection than tunneled central venous catheters. Reference: Camp-Sorrell, D., & Matey, L. (Eds.). (2017). Access device standards of practice for oncology nursing. Pittsburgh, PA: Onco...

A patient demonstrates an adequate understanding of the teaching provided regarding chemotherapy and myelosuppression by stating: "Myelosuppression is: a potential side effect of many cancer treatments." unintentional prior to a bone marrow transplant." when laboratory values show an elevation in the white blood cell count." the overreaction of the body's immune system to a medication." - correct answer a potential side effect of many cancer treatments." Answer: Chemothera...

Which of the following cancers is associated with the development of disseminated intravascular coagulation? Mucin-secreting adenocarcinoma of the breast Nonhyperdiploid variant multiple myeloma Primary peritoneal carcinoma Acral lentiginous melanoma Mucin-secreting adenocarcinoma of the breast Answer: The incidence of disseminated intravascular coagulation is associated mostly with mucin-secreting adenocarcinomas of the prostate, lung, and breast. Reference: Kaplan, M. (Ed.). (201...